for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
  Medtech Insight
  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1876-8008
   Published by Informa plc Homepage  [14 journals]
  • Medherant: Adhesive Patch For Transdermal Drug Delivery
    • Abstract: Medherant Ltd.'s drug delivery patch technology can accommodate medium or low potency drugs at a suitable saturation level to permeate the skin but without compromising adhesion, which existing patch technology has failed to achieve. This means that low potency drugs such as ibuprofen – the company's first product – can now be formulated into a patch rather than only being available in topical gel or cream.
      PubDate: Tue, 28 Jul 2015 09:00:01 -040
       
  • FDA Relies On Short-Term Data To Approve Medtronic's Recapturable TAVR
           System
    • Abstract: The approval comes less than a week after FDA approved Edwards' Sapien 3 third-generation transcatheter aortic replacement valve. Both devices were approved based on short-term outcomes data instead of the two-year data FDA has required of TAVR systems in the past.
      PubDate: Tue, 14 Jul 2015 12:00:02 -040
       
  • A Device For Hypertension After All'
    • Abstract: Despite industry-wide contraction last year after Medtronic's SYMPLICITY, some believe a hypertension device is just around the corner. With a market estimated in the billions or even tens of billions of dollars, both Medtronic and Boston Scientific are launching redesigned studies, and a determined handful of medtech start-ups continue to pursue a device-based solution for treating hypertension with invasive and noninvasive approaches, including renal sympathetic denervation through radiofrequency, ultrasound, or drugs; neuromodulation in the forearm; and cold therapy to specialized cells in ...
      PubDate: Tue, 14 Jul 2015 00:05:01 -040
       
  • All Eyes On Ophthalmic Devices Market
    • Abstract: In the ophthalmic device sector, intraocular lens surgery is expanding way beyond the cataract market with paradigm shifting technology. The vast presbyopia market now has an FDA-approved "corneal inlay" option, micro invasive glaucoma surgery has created an entirely new device segment, and corneal cross-linking has the potential to transcend its role as an effective treatment for a corneal disease to possibly being the next big thing in the non-surgical treatment of refractive errors.
      PubDate: Tue, 14 Jul 2015 00:01:50 -040
       
  • BrainScope’s Head Injury Assessment Device Moves Closer To Military,
           Sports Use
    • Abstract: BrainScope received 510(k) clearance in May for Ahead 200, a second-generation, handheld, noninvasive device for the adjunctive assessment of traumatic brain injury in adults over 18 years of age. With an estimated 60 million cases of TBI annually worldwide, the company is initially focusing on military and sports applications, but is also looking at emerging markets such as India and China, where there are fewer CT scanners and the rate of head injury is substantially higher than in the US.
      PubDate: Tue, 14 Jul 2015 00:01:43 -040
       
  • Emerging PAD Devices Impress With New Trial Results, Funding
    • Abstract: Two very different ways to treat peripheral arterial disease – lithotripsy combined with angioplasty and nitinol Tack implants – have demonstrated impressive six-month and one-year clinical results, respectively, and companies with these devices continue to attract funding.
      PubDate: Tue, 14 Jul 2015 00:01:31 -040
       
  • First Minimally Invasive Vascular Access Technology Has Potential to
           Revolutionize Growing Hemodialysis Market
    • Abstract: With a projected worldwide market of over three million hemodialysis patients by 2020, TVA Medical Inc. sees a potential $1 billion+ annual market opportunity with everlinQ, a minimally invasive, catheter-based system that allows physicians to use an endovascular approach to create an arteriovenous fistula (AVF) for vascular access in chronic kidney patients who require ongoing hemodialysis.
      PubDate: Tue, 14 Jul 2015 00:01:22 -040
       
  • The Digital Health Care Revolution Picks Up Speed
    • Abstract: The excitement about digital health solutions has reached new heights as the market moves toward changes where those solutions are not only wanted, but in many cases needed to help battle costs and improve patient outcomes. The interest in digital health is part of a larger trend that is seeing patients take on more and more responsibility for their own health amid changing perceptions of what is considered a medical device.
      PubDate: Tue, 14 Jul 2015 00:01:04 -040
       
  • Innovation In The Age Of Breast-Conserving Surgery
    • Abstract: Medical device and diagnostic companies are developing innovative new products for women with breast cancer designed to facilitate earlier diagnosis, improve diagnostic accuracy, increase surgical precision, and enable the least invasive, most breast-conserving approach to breast cancer surgery. With the number of breast cancer cases in the US projected to increase dramatically by 2030, the success of these technologies depends on their ability to improve cosmetic results and survival rates while lowering overall health care costs.
      PubDate: Tue, 14 Jul 2015 00:00:55 -040
       
  • Philips' New Commercial Model Eschews Heavy Capital Investment
    • Abstract: Innovation is critical for medtech companies to stay ahead of the game and ensure continuous growth – but sometimes, this innovation does not necessarily have to come in the form of new technologies. Neil Mesher, managing director of Philips Healthcare UK & Ireland, tells Clinica how the company has developed a new ultrasound service – of which data analytics is a key enabler – that not only addresses fundamental challenges faced by mature health care systems, but also could potentially reinvigorate revenue stream.
      PubDate: Tue, 14 Jul 2015 00:00:49 -040
       
  • Reimbursement Unraveled: Will New French Medtech Innovation Plans Hit The
           Spot'
    • Abstract: Securing reimbursement for innovative medical devices in France calls for high levels of human and financial input. Yet the often cumbersome and misfiring adoption procedures deter manufacturers from approaching this ostensibly attractive medical device market – Europe’s second largest.
      PubDate: Tue, 14 Jul 2015 00:00:44 -040
       
  • MaRVis Medical: Guidewires For MRI-Guided Interventions
    • Abstract: The growing trend of using magnetic resonance imaging for enhanced visualization during medical interventions is being augmented by non-ferromagnetic guidewires that don't dislocate in the magnetic field; don't heat or conduct electricity, and don't create imaging artifacts that obscure or distort the target image. A portfolio of MR-safe guidewires from Germany-based MaRVis Medical GMBH fulfills these requisites by successfully integrating good mechanical and visualization properties.
      PubDate: Tue, 14 Jul 2015 00:00:39 -040
       
  • Harpoon Medical: Beating-Heart Mitral Valve Repair
    • Abstract: Harpoon Medical's Inc.'s beating heart mitral valve procedure uses an expanded polytetrafluorethylene anchor that replaces the non-functioning natural chordae tendineae. The anchor is inserted via a small incision between the ribs and into the leaflet to eliminate mitral valve regurgitation.
      PubDate: Tue, 14 Jul 2015 00:00:32 -040
       
  • InPress Technologies: Halting Postpartum Hemorrhage
    • Abstract: There are approximately 140,000 fatalities a year from post-partum hemorrhage, mostly in low- to middle-income countries, and thus a pressing need to reduce mortality. A new low-pressure suction device from InPress Technologies Inc. that is inserted into the uterus following childbirth has the potential to initiate blood control within two minutes and reach full restoration of uterine tone in just over two hours.
      PubDate: Tue, 14 Jul 2015 00:00:22 -040
       
  • Medical Device Deals Update, June-July 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2015.
      PubDate: Tue, 14 Jul 2015 00:00:10 -040
       
  • Medtech Execs On The Move, June-July 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 14 Jul 2015 00:00:00 -040
       
  • Orthopedics: Bracing For Change
    • Abstract: Despite ongoing economic pressures, the worldwide orthopedic market grew 3% in 2014, reaching $34.7 billion. Although consolidation continues to cause uncertainty and disruption in this space, manufacturers at this year’s AAOS meeting were upbeat about the future as they brace for changes in the competitive landscape, health care delivery, and reimbursement.
      PubDate: Fri, 29 May 2015 00:05:20 -040
       
  • Medtronic Hints At Greater Diagnostic Focus
    • Abstract: At the IATI Biomed conference held in Tel Aviv in May, Medtronic executives hint at an increasing focus on diagnostics, personalized medicine, and patient outcomes.
      PubDate: Fri, 29 May 2015 00:05:09 -040
       
  • Prevention/Innovation Key To Driving Down Hospital Infections
    • Abstract: The US market for infection control and biosafety products will see strong growth ahead as hospitals continue the battle against health care-associated infections with innovative products and services designed to prevent needlesticks, nosocomial infections, and the spread of antibiotic-resistant organisms.
      PubDate: Fri, 29 May 2015 00:05:01 -040
       
  • Medical Device Deals Update, May 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced April-May 2015.
      PubDate: Fri, 29 May 2015 00:01:04 -040
       
  • Glyconics: Infrared Spectroscopy To Detect And Manage COPD
    • Abstract: Chronic obstructive pulmonary disease remains a particularly difficult disease to accurately diagnose, with little improvement over the last 30 years. UK-based Glyconics Ltd. hopes to reliably detect COPD with an easy, five-minute, in-office procedure that uses a sputum sample to identify a handful of proprietary biomarkers specific for the disease.
      PubDate: Fri, 29 May 2015 00:00:58 -040
       
  • Navigate Surgical Technologies: CT-Guided Dental Surgical Navigation
    • Abstract: The percentage of dentists placing dental implants could increase substantially in the coming months and years, thanks in part to a real-time, cone beam computed tomography (CBCT) guided surgical navigation system scaled to an accessible level for a general practitioner. Inliant Clinical from Navigate Surgical Technologies Inc. uses optical motion tracking to increase drilling accuracy and streamline procedure workflows.
      PubDate: Fri, 29 May 2015 00:00:54 -040
       
  • IBM Forms Health Company, Forges Partnerships With Apple, J&J, And
           Medtronic
    • Abstract: Computing giant IBM has become the latest tech company to move into the health care space, setting up a dedicated business unit, IBM Watson Health, and signing up a slew of big-hitting partners.
      PubDate: Fri, 29 May 2015 00:00:44 -040
       
  • Medtech Execs On The Move, May 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Fri, 29 May 2015 00:00:37 -040
       
  • 3D Printing: Will Personalized Medical Devices Be The Next Big Thing'
    • Abstract: Medical device manufacturers have a growing interest in 3D printing, a technology that could upend the manufacturing and distribution of certain medical devices and expand the scope of personalized medicine – especially in orthopedics, where it's used for some models, implants, and surgical cutting guides. Despite uncertainties related to regulation, reimbursement, and scaling up, global 3D printing revenues for medical and dental applications reached an estimated $537.1 million in 2014.
      PubDate: Fri, 29 May 2015 00:00:26 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015